Page 202 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 202
Liver Immunology Including Viral Hepatitis (Cont.)
TOP 10% IMPROVING NATURAL KILLER CELLS CYTOTOXICTY AND
YI P0482 HARNESSING HEPATOCYTE CANCER PROGRESSION BY
MIR-486-5P
Aya A. Bassiouni*, Mai A. Rahmoon, Rana A. Youness, Asmaa I. Gomaa,
Imam Waked, Gamal Esmat, Hend M. El Tayebi, Ahmed I. Abdelaziz,
Egypt
TOP 10% CHANGES IN LIVER IMMUNITY UPON HBV INFECTION:
YI P0483 A COMPARISON OF HUMANISED MICE AND HUMANS
Lu-En Wai*, Choong Tat Keng, Dahai Zheng, Alfonso Tan-
Garcia, Erica Ceccarello, Christine Tham, Anthony Tan Tanoto,
Antonio Bertoletti, Qingfeng Chen, Singapore
TOP 10% CD3(+)CD56(+) NK-LIKE T CELLS SHOW REDUCED
YI P0484 ANTI-VIRAL ACTIVITY IN ACUTELY HCV/HIV INFECTED
PATIENTS
ePOSTERS Pavlos Kokordelis*, Benjamin Krämer, Christoph Boesecke,
Esther Voigt, Patrick Ingiliz, Andreas Glässner, Franziska Wolter,
Christian P. Strassburg, Ulrich Spengler, Jürgen K. Rockstroh,
Jacob Nattermann, Germany
TOP 10% FUNCTIONAL IMMUNE RESTORATION CORRELATES
YI P0485 WITH HBSAG DECLINE AND MAY PREDICT TREATMENT
RESPONSE ON SEQUENTIAL NUC THERAPY IN CHRONIC
HEPATITIS B
Upkar S. Gill*, Dimitra Peppa, Lorenzo Micco, Harsimran D. Singh,
Graham R. Foster, Mala K. Maini, Patrick T. Kennedy,
The United Kingdom
TOP 10% HEPATIC APOPTOSIS INFLUENCED BY DEFICIENCY OF
YI P0486 GROUP VIA CALCIUM-INDEPENDENT PHOSPHOLIPASE A2
LEADS TO PRO-INFLAMMATORY RESPONSE BY KUPFFER
CELLS
Johannes Inhoffen*, Wang Wei, Sabine Tuma-Kellner, Wolfgang Stremmel,
Walee Chamulitrat, Germany
YI P0487 DOMINANCE OF HLA-B RESTRICTED VIRUS-SPECIFIC
CD8+ T CELL EPITOPES IN CHRONIC HBV INFECTION
Julia Lang*, Muthamia Kiraithe, Robert Thimme, Christoph Neumann-
Haefelin, Germany
202 The International Liver Congress™ 2015 • ILC Programme
TOP 10% IMPROVING NATURAL KILLER CELLS CYTOTOXICTY AND
YI P0482 HARNESSING HEPATOCYTE CANCER PROGRESSION BY
MIR-486-5P
Aya A. Bassiouni*, Mai A. Rahmoon, Rana A. Youness, Asmaa I. Gomaa,
Imam Waked, Gamal Esmat, Hend M. El Tayebi, Ahmed I. Abdelaziz,
Egypt
TOP 10% CHANGES IN LIVER IMMUNITY UPON HBV INFECTION:
YI P0483 A COMPARISON OF HUMANISED MICE AND HUMANS
Lu-En Wai*, Choong Tat Keng, Dahai Zheng, Alfonso Tan-
Garcia, Erica Ceccarello, Christine Tham, Anthony Tan Tanoto,
Antonio Bertoletti, Qingfeng Chen, Singapore
TOP 10% CD3(+)CD56(+) NK-LIKE T CELLS SHOW REDUCED
YI P0484 ANTI-VIRAL ACTIVITY IN ACUTELY HCV/HIV INFECTED
PATIENTS
ePOSTERS Pavlos Kokordelis*, Benjamin Krämer, Christoph Boesecke,
Esther Voigt, Patrick Ingiliz, Andreas Glässner, Franziska Wolter,
Christian P. Strassburg, Ulrich Spengler, Jürgen K. Rockstroh,
Jacob Nattermann, Germany
TOP 10% FUNCTIONAL IMMUNE RESTORATION CORRELATES
YI P0485 WITH HBSAG DECLINE AND MAY PREDICT TREATMENT
RESPONSE ON SEQUENTIAL NUC THERAPY IN CHRONIC
HEPATITIS B
Upkar S. Gill*, Dimitra Peppa, Lorenzo Micco, Harsimran D. Singh,
Graham R. Foster, Mala K. Maini, Patrick T. Kennedy,
The United Kingdom
TOP 10% HEPATIC APOPTOSIS INFLUENCED BY DEFICIENCY OF
YI P0486 GROUP VIA CALCIUM-INDEPENDENT PHOSPHOLIPASE A2
LEADS TO PRO-INFLAMMATORY RESPONSE BY KUPFFER
CELLS
Johannes Inhoffen*, Wang Wei, Sabine Tuma-Kellner, Wolfgang Stremmel,
Walee Chamulitrat, Germany
YI P0487 DOMINANCE OF HLA-B RESTRICTED VIRUS-SPECIFIC
CD8+ T CELL EPITOPES IN CHRONIC HBV INFECTION
Julia Lang*, Muthamia Kiraithe, Robert Thimme, Christoph Neumann-
Haefelin, Germany
202 The International Liver Congress™ 2015 • ILC Programme
